Navigation Links
CTI Receives NASDAQ Letter
Date:9/5/2008

SEATTLE, Sept. 6 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq: CTICD; and MTA: CTIC) announced that today, the Company received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC indicating that the Company is not in compliance with the $50,000,000 minimum market value of listed securities requirement set forth in NASDAQ Marketplace Rule 4450(b)(1)(A). Furthermore, the Company does not comply with NASDAQ Marketplace Rule 4450(b)(1)(B), which is an alternative to Rule 4450(b)(1)(A), and requires total assets and revenue of $50,000,000 each for the most recently completed fiscal year or two of the last three most recently completed fiscal years.

If the Company does not regain compliance by October 6, 2008, the Staff will notify the Company that its securities will be delisted. However, the Company may appeal the Staff's determination to delist its securities to a Listing Qualifications Panel. Alternatively, in the event the Company does not believe that it will be able to regain compliance, the Company intends to apply to transfer its securities to the NASDAQ Capital Market, which would continue to allow trading in the Company's securities.

The Company has been provided 30 calendar days, or until October 6, 2008, to regain compliance. The Staff advises that such compliance can be achieved if, at any time before October 6, 2008, the market value of the listed securities of the Company's common stock is $50,000,000 or more for a minimum of 10 consecutive business days.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. BioMS Medicals lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA
2. Repligen Receives Research Grants to Support Friedreichs Ataxia Development Program
3. ESA Receives 2008 Frost & Sullivan North American Technology Innovation Award for Development of Integrated Metabolomics Systems
4. Moffitt Cancer Center Receives Prestigious SPORE Grant Worth More Than $10 Million
5. Barr Receives Approval for Generic Version of Razadyne(R) Tablets
6. Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay
7. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
8. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
9. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
10. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
11. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ec. 2 The world,s first concept de...gy, a breakthrough alternative to replace a petroc...f synthetic rubber with renewable biomass, made th...ire will be on display at a lounge in the common d...ort throughout December 21, while the other tire w...
(Date:12/2/2009)...E, Mass., Dec. 2 TechConnect World...logy development and product integration in cleant...ember 11th deadline for technology abstracts and b... TechConnect World, in association with the Nano S...ean Technology and Sustainable Industries Organiza...
(Date:12/2/2009)...ec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris In...lobal biopharmaceutical company focused on endocri...U.S. Food and Drug Administration (FDA) has grante...t pathway inhibitor compound, perifosine (KRX-0401...le myeloma. Keryx Biopharmaceuticals, Inc. ("Keryx...
(Date:12/1/2009)..., Nev., Dec. 1 PDL BioPh...revenue guidance for the fourth quarter ended Dece...pared with $69 million for the fourth quarter of 2...he first of two installment payments of $12.5 mill... 2008 results was a one-time $1.8 million payment ...
Breaking Biology Technology:The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...JUPITER, Fla., Jan. 13 Level 3 Inspection LLC (L3...nt System (QMS) development by,meeting or exceedin...,Certification under the rules of the aerospace st...mpliance and zero non-compliance issues. , Sta..., Scott McAfee led,the creation, organization and ...
...TAI,AN CITY, China, Jan. 13 /PRNewswire-Asia-First...in Board: CBPO) ("China Biologic" or the "Company"...ompanies in the People,s,Republic of China ("PRC")...,Products Co., Ltd. ("Taibang"), a Chinese subsidi... loan ("the Loan Agreement") with the Bank of Chin...
...BOSTON, Jan. 13 Responding to the increased risk ...ional Patient Safety Foundation,has announced that...ly address,this issue through an extensive program...dees with the new thinking and tools critical to k...wscom.com/cgi-bin/prnh/20080307/AQF053LOGO ) , ...
Other Biology Technology:Level 3 Inspection Achieves 100% Compliance in ISO 9001 & AS 9100 Certification 2China Biologic Products Enters into Short-Term Loan Agreement 2China Biologic Products Enters into Short-Term Loan Agreement 3Patient Safety in Challenging Economic Times is Focus of NPSF Annual Congress on May 20-22 2
(Date:12/1/2009)... . , Brown adipose tissue is different from wh...miniature power stations which among other things ...ate a voltage similar to that of a battery, which ...er, the mitochondria of brown fat cells have a sho... The energy released when the fat is broken down i...
(Date:12/1/2009)...Inserm Grand Prix., Every year since 2000, Inser... outstanding,work performed in its laboratories a...ds to,demonstrate the diversity and wealth of act...d,health research, and the creativity and passion...s research each day. The Inserm 2009 prize-giving ...
(Date:12/1/2009)...ire/ -- iQor, a global provider of business proces...2009 InfoWorld 100 Awards Top 100 IT project of ...This was the first submission for iQor. ,, "We ...s list of companies," said Vikas Kapoor, president...g the way we do business, allowing us to work fast...
Breaking Biology News(10 mins):Brown fat cells make 'spare tires' shrink 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Need for At Home Blood Pressure Monitoring Underscored by High Profile Cardiac Deaths 52097 1Need for At Home Blood Pressure Monitoring Underscored by High Profile Cardiac Deaths 52097 2Need for At Home Blood Pressure Monitoring Underscored by High Profile Cardiac Deaths 52097 3Cytokine PharmaSciences Initiates Phase I Study of Oral Anti Inflammatory Agent CPSI 2364 4746 1Cytokine PharmaSciences Initiates Phase I Study of Oral Anti Inflammatory Agent CPSI 2364 4746 2l a Hospitals Struggle for Emergency Room Care Pay Physicians High Fees for On Call Coverage 52092 1l a Hospitals Struggle for Emergency Room Care Pay Physicians High Fees for On Call Coverage 52092 2
...o manipulate computer cursors for fruit juice rewa...ter plans behaviors not by specifying movements re...at will result from those actions. , The distincti...t yields new basic insight into a central function...n, called the lateral prefrontal cortex (PFC). ,...
...en under age 6 in Massachusetts over 22 years, a n...pecially infants--are now more likely to be overwe...bulatory Care and Prevention of Harvard Medical Sc...n the July issue of Obesity. , "The obesity epidem...dren," says Matthew Gillman, MD, senior author of ...
... for alcohol has yielded a rapid, inexpensive way ...ke beat cops keeping misguided cells from attackin...mbers of these cells opens the door to improved tr...iseases such as type 1 diabetes and arthritis, Med...ls are components of the immune system designed to...
Other Biology News:Himalayan forests disappearing 2Today's babies are fatter babies 2Finding paves way for better treatment of autoimmune disease 2
...ings together UV irradiation and antimicrobial sta...gainst PCR contamination! Quickly inactivate DNA ...ironment with antimicrobial coated stainless steel...utes with built-in 30-minute timer UVP's Sterili...
Ascent Software for Fluoroskan Ascent/Fluoroskan Ascent FL from Thermo Scientific
Lambda Protein Phosphatase from New England Biolabs
Porcine Angiotensin Converting Enzyme from BIOPUR
Biology Products: